Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: Foreign ADRs, Added, 2023 Q2

CITADEL ADVISORS LLC historic quarter change: Foreign ADRs, Added

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 793 positions, added to 554, reduced 514 and sold out of 741.

  • Q2 2023: Stock ABCAM PLC; Country of operation —; Class ADS; Shares before 102,318.
  • Q2 2023: Stock CRH PLC; Country of operation —; Class ADR; Shares before 430,103.
  • Q2 2023: Stock WNS HLDGS LTD; Country of operation —; Class SPON ADR; Shares before 72,222.
  • Q2 2023: Stock AMBRX BIOPHARMA INC; Country of operation —; Class SPONSORED ADS; Shares before 707,133.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2023ABCAM PLC
CUSIP 000380204
—ADS102,3186,887,225+6,784,907$1,377,200$168,530,395+$167,153,1952023-08-14
Q2 2023CRH PLC
CUSIP 12626K203
—ADR430,103763,248+333,145$21,879,340$42,535,811+$20,656,4712023-08-14
Q2 2023WNS HLDGS LTD
CUSIP 92932M101
—SPON ADR72,222289,661+217,439$6,728,924$21,353,809+$14,624,8852023-08-14
Q2 2023AMBRX BIOPHARMA INC
CUSIP 02290A102
—SPONSORED ADS707,133727,022+19,889$6,307,626$11,966,782+$5,659,1562023-08-14
Q2 2023AVADEL PHARMACEUTICALS PLC
CUSIP 05337M104
—SPONSORED ADR318,481486,195+167,714$2,917,286$8,012,493+$5,095,2072023-08-14
Q2 2023CHINDATA GROUP HLDGS LTD
CUSIP 16955F107
—ADS1,293,6541,840,195+546,541$9,042,642$13,175,796+$4,133,1542023-08-14
Q2 2023LUFAX HOLDING LTD
CUSIP 54975P102
—ADS REP SHS CL A5,486,1795,703,887+217,708$11,191,805$8,156,559-$3,035,2462023-08-14
Q2 2023NATURA &CO HLDG S A
CUSIP 63884N108
—ADS439324,765+324,326$2,292$2,263,612+$2,261,3202023-08-14
Q2 2023ADAPTIMMUNE THERAPEUTICS PLC
CUSIP 00653A107
—SPONDS ADR1,127,0183,370,083+2,243,065$1,228,450$3,117,327+$1,888,8772023-08-14
Q2 2023EMEREN GROUP LTD
CUSIP 75971T301
—SPONSORED ADS12,415453,229+440,814$55,247$1,717,738+$1,662,4912023-08-14
Q2 2023COMPANHIA PARANAENSE ENERG C
CUSIP 20441B605
—SPON ADS169,531299,769+130,238$1,139,248$2,581,011+$1,441,7632023-08-14
Q2 2023GRUPO SUPERVIELLE S.A.
CUSIP 40054A108
ArgentinaSPONSORED ADR6,704306,634+299,930$15,084$953,632+$938,5482023-08-14
Q2 2023VERONA PHARMA PLC
CUSIP 925050106
—SPONSORED ADS268,248285,866+17,618$5,386,420$6,043,207+$656,7872023-08-14
Q2 2023EDAP TMS S A
CUSIP 268311107
FranceSPONSORED ADR56,300118,201+61,901$623,241$1,089,813+$466,5722023-08-14
Q2 2023TOTALENERGIES SE
CUSIP 89151E109
—SPONSORED ADS9,09016,021+6,931$536,765$923,450+$386,6852023-08-14
Q2 2023JAMES HARDIE INDS PLC
CUSIP 47030M106
—SPONSORED ADR31,80739,511+7,704$688,622$1,062,451+$373,8292023-08-14
Q2 2023BANCO BBVA ARGENTINA S A
CUSIP 058934100
ArgentinaSPONSORED ADS43,49384,231+40,738$170,493$516,336+$345,8432023-08-14
Q2 2023MYT NETHERLANDS PARENT B V
CUSIP 55406W103
NetherlandsADS78,67787,309+8,632$553,099$349,236-$203,8632023-08-14
Q2 2023TRIVAGO N V
CUSIP 89686D105
—SPON ADS A SHS135,208274,532+139,324$204,164$362,382+$158,2182023-08-14
Q2 2023LIANBIO
CUSIP 53000N108
—SPONSORED ADS111,762126,057+14,295$217,935$287,410+$69,4752023-08-14
Q2 2023PURPLE BIOTECH LTD
CUSIP 74638P109
—SPONSORED ADS15,17545,944+30,769$26,708$64,322+$37,6142023-08-14
Q2 2023LIZHI INC
CUSIP 53933L104
—ADS1,71637,651+35,935$1,304$34,262+$32,9582023-08-14
Q2 2023ZEPP HEALTH CORPORATION
CUSIP 98945L105
—SPONSORED ADS61,57091,762+30,192$80,657$104,609+$23,9522023-08-14
Q2 2023ZHIHU INC
CUSIP 98955N108
—ADS5,66727,317+21,650$7,197$30,868+$23,6712023-08-14
Q2 2023TRINITY BIOTECH PLC
CUSIP 896438306
—SPON ADR NEW22,27137,622+15,351$20,935$36,313+$15,3782023-08-14
Q2 2023ORCHARD THERAPEUTICS PLC
CUSIP 68570P200
—SPON ADS NEW123,313125,521+2,208$662,191$651,454-$10,7372023-08-14
Q2 2023PINTEC TECHNOLOGY HLDGS LTD
CUSIP 72352G206
—SPONSORED ADS57,42772,008+14,581$62,021$68,415+$6,3942023-08-14
Q2 2023KUKE MUSIC HLDG LTD
CUSIP 501229108
—SPONSORED ADS24,68240,185+15,503$27,150$23,910-$3,2402023-08-14
Q2 2023PHOENIX NEW MEDIA LTD
CUSIP 71910C202
—SPONSORED ADS16,15317,589+1,436$36,829$34,650-$2,1792023-08-14
Q2 2023PHAXIAM THERAPEUTICS S A
CUSIP 29604W108
—SPONSORED ADR10,80716,606+5,799$10,591$12,122+$1,5312023-08-14
Q2 202317 ED & TECHNOLOGY GROUP INC
CUSIP 81807M205
—ADS126,174133,624+7,450$127,436$126,007-$1,4292023-08-14
Q2 2023AMBOW ED HLDG LTD
CUSIP 02322P200
—SPONSORED ADS11,07014,213+3,143$2,935$3,162+$2272023-08-14